enVVeno Medical Corp. (NVNO)
11.49
+0.05
(+0.44%)
USD |
NASDAQ |
Sep 08, 16:00
enVVeno Medical Enterprise Value : -13.25M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | -13.25M |
| September 04, 2026 | -13.28M |
| September 03, 2026 | -13.51M |
| September 02, 2026 | -13.38M |
| September 01, 2026 | -13.59M |
| August 31, 2026 | -13.26M |
| August 28, 2026 | -13.75M |
| August 27, 2026 | -13.42M |
| August 26, 2026 | -13.26M |
| August 25, 2026 | -13.71M |
| August 24, 2026 | -14.02M |
| August 21, 2026 | -14.06M |
| August 20, 2026 | -13.99M |
| August 19, 2026 | -13.93M |
| August 18, 2026 | -13.55M |
| August 17, 2026 | -13.04M |
| August 14, 2026 | -13.58M |
| August 13, 2026 | -13.68M |
| August 12, 2026 | -13.58M |
| August 11, 2026 | -13.49M |
| August 10, 2026 | -14.15M |
| August 07, 2026 | -13.84M |
| August 06, 2026 | -14.15M |
| August 05, 2026 | -13.53M |
| August 04, 2026 | -13.48M |
| Date | Value |
|---|---|
| August 03, 2026 | -13.78M |
| July 31, 2026 | -13.85M |
| July 30, 2026 | -13.83M |
| July 29, 2026 | -13.98M |
| July 28, 2026 | -13.98M |
| July 27, 2026 | -13.80M |
| July 24, 2026 | -13.99M |
| July 23, 2026 | -14.18M |
| July 22, 2026 | -14.16M |
| July 21, 2026 | -14.15M |
| July 20, 2026 | -13.56M |
| July 17, 2026 | -13.72M |
| July 16, 2026 | -14.08M |
| July 15, 2026 | -13.74M |
| July 14, 2026 | -13.65M |
| July 13, 2026 | -13.58M |
| July 10, 2026 | -13.34M |
| July 09, 2026 | -13.58M |
| July 08, 2026 | -13.50M |
| July 07, 2026 | -13.56M |
| July 06, 2026 | -13.51M |
| July 02, 2026 | -13.50M |
| July 01, 2026 | -13.69M |
| June 30, 2026 | -13.77M |
| June 29, 2026 | -17.08M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 210.25B |
| AngioDynamics, Inc. | 591.77M |
| Alphatec Holdings, Inc. | 1.912B |
| AtriCure, Inc. | 2.639B |
| Baxter International, Inc. | 19.53B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.60M |
| Total Expenses (Quarterly) | 3.60M |
| EPS Diluted (Quarterly) | -5.365 |
| Earnings Yield | -217.9% |
| Normalized Earnings Yield | -216.17 |